Michel Giunta MD
Participe à 1 Session
Sessions auxquelles Michel Giunta MD participe
3:35 PM
3:35 PM
Treatment switch from aflibercept to ranibizumab in Canadian DME patients in a real-world setting: the PRECISE study 237
8 minutes,
3:35 PM
- 3:43 PM
Partie de:
Rétine I
Paper Presentation | Présentation d'article
Michel Giunta MD (Conférencier.ère)